Cancer patients missing out on best treatment because of cost
Cancer patients are missing out on high-tech radiotherapy because the NHS is struggling to invest in staff and technology.Intensity modulated radiotherapy, which has been used in Europe and the US for a decade, is used to treat only 7 per cent of eligible NHS patients, according to research by the ...
You need to be signed in to read more
Subscribe for unlimited access
With a HSJ subscription you’ll unlock:
- All of HSJ.co.uk and our HSJ mobile app
- News and insight on all areas of public funded healthcare
- Expert commentary, insight and analysis from industry leaders
- 9 weekly ‘Expert Briefing’ insight emails covering a variety of specialist topics